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Abstract
Background: To investigate the roles of androgen receptor (AR) in epithelial- mesenchymal transition (EMT) in
human prostate cancer stem progenitor (S/P) cells isolated from LNCaP cell line.
Methods: The S/P cells were obtained from LNCaP cell line through florescence-activated cell sorting (FACS). AR was
overexpressed in S/P cells through lentivirus. Western blot assay was used to detect the EMT markers expression, such
as E Cadherin, N Cadherin, Vimentin and Snail. MTT assay, soft agar colony formation assay, sphere formation assay and
migration assay were used to investigate AR’s roles in EMT of S/P cells. Cell signaling pathways associated with
proliferation and apoptosis of S/P cells were detected simultaneously. And S/P cells were treated with in vitro
combinatory use of LY 294002 (inhibitor of AKT signaling molecules) with γ-TT and/or 5-AZA.
Results: Our data showed that S/P cells from LNCaP had high EMT markers expression, more tumorigenesis and
strong migration ability. And in S/P cells overexpressed with AR, the expression of EMT markers decreased. In
addition, these cells had less proliferation ability, tumorigenesis ability, self-renewal and migration ability. At the
same time, targeting S/P cells with AKT signaling pathway inhibitor LY29004 andγ-TT and/or 5-AZA could inhibit
S/P cell’s proliferation and tumorigenesis.
Conclusions: Our data suggest that AR played a negative role in EMT of PCa S/P cells, by regulating AKT cell
signaling pathway, which could be a new strategy to treat castration resistant prostate cancer (CRPC).
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Background
Prostate cancer is the most common malignancy in the
world and the second most common cause of cancer-
related mortality in men [1]. Early prostate cancer (T1-
T2) can undergo radical surgery or radiation therapy,
the curative effect is good. For locally advanced or meta-
static prostate cancer (T3-T4), endocrine therapy is the
preferred method. Unfortunately, after 1–3 years, the tu-
mors ultimately progress and become castration resist-
ant prostate cancer (CRPC). This is the end stage of
prostate cancer and is the bottleneck of treatment. The
mechanism of CRPC advance, why the tumor is not sen-
sitive to chemotherapy, was not completely clear.
More and more evidence indicate that the cancer stem
cells (CSC) exist objectively and play an important role
in the tumorigenesis and progression of the tumors
[2,3]. This part takes up only a small percentage of all
cancer cells, but is closely related to tumor recurrence
and metastasis. Many research has shown that cancer
drug resistance to chemotherapy is associated with CSC,
which have the potential for self-renewal, differentiation,
strong migration and invasion ability [4, 5]. Cell signal-
ing pathways related to maintain stem cell self-renewal
and proliferation include PI3K/AKT, Wnt, STAT3/5,
EGF/EGFR and so on [6-9]. Preliminary works from our
research group showed that after endocrine therapy, the
prostate cancer stem/progenitor (S/P) cells increased in
tumor tissue of the patients, which further confirmed
the role of S/P cells in prostate cancer progression [10].* Correspondence: zhifangma@163.com
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The epithelial- mesenchymal transition (EMT) is the
process that in a particular physiological and patho-
logical conditions, the epithelial cells transfer to mesen-
chymal cells, involving in multiple genes and multi-step,
the intercellular adhesion weakening and cell movement
strengthening. EMT provides such a basis for epithelial
tumor cells. Lue’s research [11] had shown that a zinc
transporter LIV1 could promote EMT and metastasis of
prostate cancer cells. This procedure is mediated
through ERK signaling pathway. Other studies have
found that BMP7 and SIRT1 could induce EMT in pros-
tate cancer PC-3 cells, and PI3K and ERK signaling
pathway was involved in this process. This promoted in-
vasion and metastasis of prostate cancer [12,13]. In
addition, the EMT markers can be detected in prostate
cancer patients, with primary tumors and bone metasta-
ses. Immunohistochemical study showed that the ex-
pression of EMT markers was higher in the edge
location cells of primary tumors and metastatic lesion
than that of the cells in the center of the tumor. Notch1
expression in bone metastases is significantly higher
than that in primary tumorsand, and may play an im-
portant role in the bone metastasis of prostate cancer
[14]. These data suggest that EMT plays an important
role in the invasion and metastasis of prostate cancer.
Consistent with this, our preliminary data showed the
cancer cells with EMT phenotype increased after endo-
crine therapy in human PCa tissue [15,16].
It was shown that EMT phenotype tumor cells had
certain features of stem cells, and some stem-like cells
had EMT features, and these two types of cells were as-
sociated with tumor drug resistance [17-19]. Androgen
receptor (AR), a member of the nuclear receptor super
family, can be activated by its ligands, androgens, to
regulate its target gene expression. Androgen/androgen
receptor (AR) signaling plays pivotal roles in the prostate
development and homeostasis as well as in the progres-
sion of prostate cancer (PCa) [20]. Whether prostate
cancer stem cells have the features of EMT and roles of
AR in this process was unclear, in this study, we would
investigate EMT characteristics in prostate cancer S/P
cells, and the roles of AR in regulating EMT and charac-
teristics of S/P cells.
Methods
Cell lines, transfection and infection
The human PCa cell lines LNCaP were purchased from
the Chinese Type Culture Collection (CTCC). LNCaP
(passage X) was maintained in a humidified incubator
(95% O2; 5% CO2) and cultured with RPMI 1640 medium
(Invitrogen, Carlsbad, CA) with 10% fetal calf serum and
2 mM glutamine (Gibco BRL), 1% penicillin and strepto-
mycin (Invitrogen). Androgen deprivation or androgen
treatment in vitro were carried out by culturing the cells
in medium containing 10% charcoal-stripped fetal calf
serum plus 1 nM 5α-dihydrotestosterone (DHT, Sigma) or
10 nM DHT. For immunocytochemical staining, cell lines
were grown on chamber slides (Thermo Fisher Scientific
Inc. MA) until confluence.
For transfection of plasmid pRetrosuperMycshRNA
(Addgene, MA) and Oligo Bcl-2 siRNA (Santa Cruz Bio-
technology, CA), cells were plated in culture dishes
24 hours before transfection and 2 days later in accord-
ance with the manufacturer’s instructions using Lipofec-
tamine Plus reagent (Invitrogen Life Technologies, CA).
After transfection, cells were used to do MTT assay. The
scrambled siRNA (Santa Cruz Biotechnology, CA)) was
used as the negative control (sc-37007).
For infection of lentivirus carrying vector or AR,
293 T cells were transfected with a mixture of DNAs
(Lentiviral vectors pWPI) (Addgene, MA) containing AR
(psPAX2 packaging plasmid, and pMD2G envelope plas-
mid, at a 4:3:2 ratio) using Lipofectamine (Invitrogen,
CA) according to the manufacturer’s protocol. After in-
fection, the media containing the virus was changed into
normal culture medium. Since the pWPI vector contains
GFP, transfection efficiency could bel monitored by de-
tecting GFP fluorescence.
The research had been performed with the approval of
the ethics committee of First Hospital of Shanxi Medical
University; written informed consent for participation in
the study was obtained from participants.
Antibodies
The antibodies c-Myc, MAPK (Erk1/2), Phospho - MAPK
(Erk1/2), Stat3, Phospho - Stat 3, AKT and Phospho -
AKT were obtained from cell signaling technology, MA,
USA. The antibodies P63, AR, Integrin β1, Bcl-2, GAPDH,
Wnt-1(G-19) and TGFβ1 were derived from Santa Cruz
Biotechnology, CA, USA. The antibodies CD133, CK8,
E Cadherin, N Cadherin, and Snail were derived from
Abcom, MA, USA. The antibody CK5 was obtained
from Covance, CA, USA. The antibody CD44 was de-
rived from eBioscience, CA, USA. The antibody Vimen-
tin was derived from Fisher Scientific, MA, USA. The
antibody Ki67 was obtained from Novocastra, Newcastle,
United Kingdom.
Florescence-activated cell sorting (FACS)
For flow cytometry, cells were dissociated with Accutase
(Innovative Cell Technologies, CA.) and washed twice in
the staining solution containing Ca2+- and Mg2+-free PBS
with 1 mM EDTA, 25 mM Hepes (pH 7.0) (Gibco BRL),
and 1% FBS. Cells were stained live in the staining solu-
tion containing conjugated anti-CD44, and anti-CD133
antibody (50 min at 4°C). Samples were analyzed on a BD
LSR II flow cytometer (Becton Dickinson Immunocyto-
metry Systems, CA). A minimum of 500,000 viable cell
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events were collected per sample. For sorting, 2 × 107 cells
were processed for CD44 and CD133 multi color staining,
along with appropriate negative controls and single-
color positive controls. The CD44+/CD133+ population
was sorted out on a BD FACS Diva cell sorter (Becton
Dickinson Immunocytometry Systems, CA, USA).
RNA extraction and quantitative real-time PCR analysis
RNA was extracted using the Trizol reagent (Invitrogen),
and first-strand cDNA was synthesized from 1 μg of
total RNA in 20 μl reactions containing RT buffer with
dNTPs, Oligo-dT, RNase inhibitor, and Moloney murine
leukemia virus reverse transcriptase according to the
manufacturer’s protocol (Invitrogen). Reverse transcrip-
tion reactions (used BIO-RAD MyCycler thermal cycler)
were incubated at 25°C for 5 min and then 42°C for
30 min, followed by 85°C for 5 min, and aliquots of the
reaction products were used in later quantitative real-
time PCR analysis. The quantitative PCR analysis was
done using BIO-RAD C1000 Thermal cycler system and
the SYBR green PCR master mix kit (Applied Biosys-
tems), according to the manufacturer’s suggestions. The
housekeeping gene, β-actin was used for normalization.
Relative mRNA expression was calculated as described.




CATTTCTCCACATTT-3; CK 5 forward, 5-GTGATG
CTGAAGAAGGATGTAG-3; reverse, 5-TCC AGG
TTG CGG TTG TTG-3; CK 8 forward, 5-TGG AGT
CTC GCC TGG AAG-3; reverse, 5-CCT CGT ACT
GTG CCT TGA C-3; CD 44 forward, 5-TTT GCA TTG
CAG TCA ACA GTC-3; reverse, 5-GTT ACA CCC
CAA TCT TCA TGT CCA C-3; PSA forward, 5-GGT
GAC CAA GTT CATGCT GTG-3; reverse, 5-GTG
TCC TTG ATC CAC TTC CG-3; AR forward, 5-TAG
CCC CCT ACG GCT ACA; reverse, 5-TTC CGA AGA
CGA CAA GAT GGA C-3; β-actin forward, 5-CAT
GTA CGT TGC TAT CCA GGC-3; reverse, 5-CTC
CTT AAT GTC ACG CAG AT-3; All samples were run
in triplicate.
Western blots
Detailed procedures had been described previously [21].
Briefly, cells were exposed to RIPA lysis buffer (with prote-
ase inhibitor), and were incubated for 30 min on ice. The
homogenate was centrifuged at 14,000 rpm for 10 min at
4°C. The protein supernatant concentration was deter-
mined using the Bradford assay from BIO-RAD Laborator-
ies. Then the protein was prepared for electrophoresis run
on SDS/PAGE gel and then transferred onto PVDF mem-
brane (Pall Corporation, FL). After the membrane was
blocked by 5% milk PBST, the first antibodies (against
c-Myc, MAPK (Erk1/2), Phospho-MAPK (Erk1/2), Stat3,
Phospho-Stat 3, AKT and Phospho – AKT, AR, Bcl-2,
GAPDH, Wnt-1(G-19) and TGFβ1) were diluted in
blocking buffer to appropriate concentrations and incu-
bated with protein blots (on PVDF membrane) individu-
ally. Following reaction with HRP-conjugated secondary
antibodies, the signals were developed with enhanced
chemiluminescence (ECL) substrate (Thermo Scientific,
IL). The band densities were digitized using Chemi-
DocTM XRS+ Imaging System (BIO-RAD Laboratories,
CA); The GAPDH protein was used as internal control.
Soft agar colony formation assay
To compare the different cells’ tumorigenetic ability, a
cell suspension (1 × 104 cells/well) in 2 mL of 0.5% low-
melting SeaPlaque CTG agarose (Cambrex Bio Science
Rockland) with RPMI 1640 was overlaid into 6-well
plates containing a 1% agar base. The 2 mL normal
medium was added on the upper cells contained agar.
All samples were plated in triplicate. The plates were in-
cubated at 37°C in a humidified incubator for 21 days.
The colonies were visualized by staining with 1% crystal
violet. The experiment was analyzed in triplicate, and
colonies larger than 1 mm in diameter were counted.
Migration and invasion assay
The migrative and invasive potential of different cells
was assessed using the 8 μm polycarbonate membrane
plate Transwell system (Corning Incorporated, NY).
Cells (1 × 105) were resuspended in 100 μl serum free
medium and added in the upper Transwell compart-
ment. 600 μl of 20% CS-FBS medium was placed in the
lower compartment to act as an attractant. 1 or 10 nM
DHT was added in the medium. After 24 hours incuba-
tion at 37°C and 5% CO2, the filters were fixed in metha-
nol for 10 min at 4°C, stained with 1% toluidine blue
(BIO-RAD, CA) for 5 min at room temperature and
then washed carefully in ddH2O. Cells that had not mi-
grated, were removed from the upper face of the mem-
branes with cotton swabs. After air dried, the
membranes were observed under light microscope. The
average number of cells per field of view (five random
fields per membrane) was counted at × 20 magnification.
For invasion assay, before the cells were planted into the
upper Transwell, 50 μl Matrigel was added on the mem-
brane. The incubation time was prolonged to 48 hours.
Each experiment was repeated at least three times and
each time the mean numbers of migrating or invading
cells were taken from three chambers.
Sphere formation assay
Single cells suspension (1 × 103, in 50 μl medium) was
mixed with Matrigel 50 μl (keep on ice before use) and
100 μl of mixture was placed along the rim of the 24
Zhifang et al. BMC Biochemistry  (2015) 16:13 Page 3 of 11
well low attached culture plates (BD, CA). Every kind of
cells was repeated three wells. The culture plate was in-
cubated in 37°C incubator for 10 min and then 500 μl
medium was added. Cells were grown in serum-free epi-
thelial basal medium with 1 or 10 nM DHT, supple-
mented with Prosta Life Life Factors (Lifeline cell
technology, Germany). Spheres were counted after 7 to
14 days under Olympus light microscope.
Immunostaining
For culture cells immunofluorescence staining, the cells
were fixed with ice cold methanol on ice for 15 min and
then washed with PBS thrice. The cells were perme-
abilized with 0.1% Triton X-100/PBS at room temperature
for 10 min and then washed with PBS. Non-specific anti-
body binding sites were blocked for 30 min with 5% bo-
vine serum albumin PBS and not be washed. Cells were
incubated with first antibodies diluted in blocking buffer
at 20°C for 2 hours. Following 3 times PBS washes, second
antibodies diluted in blocking buffer were added on the
cells at room temperature for 60 min. After air-dried, the
cells were covered by mounting solution (containing
DAPI) and visualized with an Olympus IX70 fluorescent
microscope. The separate images were obtained for Texas
Red and DAPI fluorescence, and images were overlaid
with Adobe Photoshop (Adobe Systems, CA). When the
cells were double stained, the first antibodies should be
from different resource.
Cells proliferation assay
All kinds of cells were incubated in 12–96 well dishes
(103-105 cells/well) for 6 days, 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT; 0.5 mg/mL;
Sigma) was added at days 0, 2, 4, and 6. After 2 hours of
reaction, absorbance of the converted dye was measured
at a wavelength of 570 nm with background subtraction
at 650 nm.
Statistical analysis
Data are shown as the mean ± SD. And statistical ana-
lysis was obtained using SPSS version 15.0computer soft-
ware (SPSS Inc., Chicago, IL, USA). A P-value of <0.05
was taken to indicate statistical significance.
Results
Isolating S/P cells from LNCaP cell line
The published paper by others and results of our labora-
tory’s recent studies indicated low expression level of AR
in PCa S/P cells [22,23]. In order to investigate AR’s
roles in EMT of PCa S/P cells, S/P cells were isolated
from a single androgen dependent PCa cell lineLNCaP,
using antibodies to CD133 and CD44. About 1.5% S/P
cells were isolated using FACS (Figure 1A). And the
morphology of sorted LNCaP S/P cells was shown in
Figure1B. As shown in Figure 1C, the S/P cells had
higher tumorigenicity than that of non S/P cells, when
tested using soft agar colony formation assay. Then the
stem cell markers expression of S/P cells was detected
through Western blot analysis, immunofluorescence
(IF) staining and qRT-PCR (Figure 1D-F). The S/P cells
markers, such as CD133, integrin and CK5 were
expressed higher than those of non S/P cells. Mean-
while, the mature epithelial cell markers in S/P cells,
such as AR, PSA and CK8 were expressed lower than
those of non S/P cells. These results suggested that the
isolated small number side population was S/P cells
with higher tumorigenicity.
Identification of EMT characteristics in S/P cells from
LNCaP cell line
Western blot analysis and IF staining were used to test
EMT markers expressed in S/P cells from LNCaP cell line.
Using cell extracts of parental, S/P and non S/P cellsAR,
the EMT markers including E Cadherin, N Cadherin,
Vimentin and Snailproteins were detected using Western
blot analysis. N Cadherin, Vimentin and Snailin S/P cells
were expressed higher than those in non S/P cells. How-
ever, epithelial cell marker E Cadherin was expressed low
in S/P cells (Figure 2A). IF staining results demonstrated
the similar thing (Figure 2B). As shown in Figure 2C and
D, then soft agar colony formation assay and migration
assay showed that S/P cells had higher tumorigenicity and
migration ability, than those of non S/P cells. Our data
suggested that S/P cells from LNCaP cell line showed
EMTcharacteristics.
AR was a suppressor in EMT of S/P cells from LNCaP cell
line
S/P Cells were infected with lentivirus carrying either
vector or AR and grown in two different androgen con-
centrations, charcoal stripped (CS)-FBS + 1 nM DHT,
and CS-FBS + 10 nM DHT. Western blot assay was used
to test AR, E Cadherin, N Cadherin, Vimentin and Snail
expression using cell extracts of vector S/P and AR S/P
cells. As shown in Figure 3A, the expression of EMT
markers decreased, when AR was overexpressed in S/P
cells. Then how AR affected S/P cells proliferation, was
investigated. Cells were incubated in 24 well dishes (1 ×
104 cells/well). At 0, 2, 4, and 6 days, MTT assays were
performed. The ARS/P cells proliferation was inhibited
during different DHT concentration, compared to that
of Vector S/P cells. But AR played an opposite role in
non S/P cells (Figure 3B). Soft agar colony formation
assay was used to test tumorigenicity. After incubated
for 21 days, colonies larger than 1 mm in diameter were
counted. The ARS/P cells tumorigenicity was inhibited
under different DHT concentration, compared to that of
Vector S/P cells (Figure 3C). Similarly, the self-renewal
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ability was inhibited, when AR was overexpressed in S/P
cells (Figure 3D). Moreover, the migrative potential of
ARS/P cells was inhibited in different DHT concentra-
tion, compared to that of Vector S/P cells. Meanwhile,
AR played an opposite role in non S/P cells (Figure 3E).
The signaling pathways activation related to self-renewal/
proliferation in LNCaP S/P cells
It was known that PI3K/AKT, Bcl-2, c-Myc, MAPK (Erk1/
2), TGF-ß, and Stat3 cell signaling pathways might involve
in S/P cells proliferation and apoptosis. The probably re-
lated signaling pathways in parental, S/P, and non S/P cells
of LNCaP cell line were examined using Western blot
analysis. It was found that P-AKT, Bcl-2 and c-Myc were
expressed higher in S/P cells, compared to those of non S/
P cells (Figure 4A). When LNCaP S/P cells were infected
with lentivirus carrying AR, the expression of P-Akt, bcl-
2, and c-Myc were inhibited (Figure 4B). Then to confirm
the signaling pathways related to S/P cells proliferation,
the S/P cells of LNCaP cell line were transfected with AR,
Oligo bcl-2 siRNA, or/and c-Myc siRNA plasmids indi-
cated. At the end of 4 days of culture after transfection,
cells were used to do MTTassay. It was found AR, sibcl-2,
or/and sic-Myc all could inhibit S/P cells proliferation.
Combining use of si bcl-2 with si c-Myc could show stron-
ger inhibition (Figure 4C).
In vitro combinatory use of LY 294002 with γ-tocotrienol
(γ-TT) and/or 5-aza-2′-deoxycytidine (5-AZA) showed
synergistic effect of killing PCa S/P cells
LY 294002 is an inhibitor of AKT signaling. γ-TT can
suppress S/P cells through the interruption of targeting
Figure 1 Isolating S/P cells from LNCaP cell line. (A) Flow cytometry isolation of S/P (1.5%) and non S/P (98.5%) cells. Cells were grown in regular
RPMI medium containing 5% of FBS (cells of passage number less than 3 were used for all experiments). (B) Morphology of sorted S/P cells. (C) Soft
agar assay of S/P and non S/P cells. (D) Western blot analysis of AR, CD133, Integrin β1, and CK 8 using cell extracts of parental, S/P, and non S/P cells.
(E) IF staining results using antibodies of CK5, CK8, AR, CD133 and Integrin. (F) qRT-PCR analysis results of markers of parental, S/P, and non S/P cells.
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molecules including bcl-2 and Akt. 5-AZA is a de-
methylating agent and can induce AR expression of S/P
cells. LY 294002, γ-TT and 5-AZA were used in various
combinations. Two or three reagents could suppress S/P
cells tumorigenesis and growth. Combining use of three
reagents could show stronger inhibition in soft agar col-
ony formation assay (Figure 5A). At last, MTT assay was
used to show that these reagents could suppress S/P
cells growth. It was found that the combinational use of
LY 294002, γ-TT and 5-AZA did leaded to a significant
suppression of S/P cells proliferation (Figure 5B).
Discussion
It’s believed that cancer stem/progenitor cells and EMT
played very important roles in prostate cancer develop-
ment [24]. EMT is closely related to PCa drug resistance.
EMT and stem-like cell markers expression of the
docetaxel-resistant PCa cells had increased. ZEB1 siRNA
transfection reverted docetaxel resistance and reduced
CD44 expression in DU-145R and PC-3R [25]. It was
shown that PCaradio resistance is associated with EMT
and enhanced CSC phenotypes via activation of the
PI3K/Akt/mTOR signaling pathway [26]. After androgen-
deprivation therapy (ADT), the S/P cells increases, which
have low AR expression. It was reported that ADT could
lead to EMT in both normal prostate and prostate cancer
tissues [15]. Sethi [14] found that the cancer cells EMT
marker expression was different at the edge of human pri-
mary tumors and bone metastasis of prostate cancer. The
expression of EMT marker Vimentin, nuclear factor-кB
(NF-кB), Notch-1 and ZEB1 increased. Meanwhile, epi-
thelial markers E Cadherin expression level was low. This
study suggested EMT was closely related to invasion and
metastasis of prostate cancer. Another study showed that
EMT phenotype could be detected in ARCaPM and
PDGF-D overexpression PC-3prostate cancer cell lines.
Compared with the ARCaPE and PC-3 cells, the tumor
formation and self-renewal capacity of these cells signifi-
cantly increased. Stem cell markers Sox2, Nanog, Oct4,
Lin28B and/or Notch1 expression significantly increased
and the cells had some characteristics of stem cells.
MiR200 could inhibit Notch1 expression, and cells tumor
formation capacity and self-renewing ability decreased.
Through Notch1 signaling pathway, MiR200 regulated
Figure 2 Identification of EMT characteristics in S/P cells from LNCaP cell line. (A) Western blot analysis of AR, E Cadherin, N Cadherin, Vimentin
and Snail using cell extracts of parental, S/P and non S/P cells. (B) IF staining results using antibodies of E Cadherin, N Cadherin and Vimentin.
(C) Soft agar colony formation assay. The plates were incubated at 37°C in a humidified incubator for 21 days. Colonies larger than 1 mm in
diameter were counted. (D) Migration assay. The migrative potential of different cells was assessed using the 8 μm pore Transwell system. The
average number of cells per field of view (five random fields per membrane) was counted at × 20 magnification.
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Figure 3 (See legend on next page.)
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characteristics of stem cells of EMT phenotype prostate
cancer cell [27]. All these results indicated that EMT has
some relationship with CSC.
Our preliminary data show that both tumor cells with
EMT markers and tumor cells with CSC markers in-
crease after ADT in tumor tissue of prostate cancer pa-
tients [10, 16]. Stem-like SP cells acquired more
complete EMT molecular features and exhibited stron-
ger aggressive capability [28]. In this research, our group
made it clear that CSC of prostate cancer had some
EMT characteristics. Compared with those of non S/P
cells, the EMT markers expression of S/P cells increased,
tumorigenesis ability and migration and invasion cap-
acity wre enhanced in S/P cells. These two kinds of cells
increased, after ADT and these may common led to the
failure of traditional endocrine treatment and disease
progress.
Androgen/androgen receptor (A/AR) axis cancer [29].
Now it was considered that prostate cancer cells varied,
and are mainly luminal cells, but there are also some
(See figure on previous page.)
Figure 3 AR is a suppressor in EMT of S/P cells from LNCaP cell line. S/P Cells were infected with lentivirus carrying either vector or AR and
grown in two different androgen concentrations, charcoal stripped (CS)-FBS + 1 nM DHT, CS-FBS + 10 nM DHT. (A) Western blot analysis of AR, E
Cadherin, N Cadherin, Vimentin and Snail using cell extracts of vector S/P and AR S/P cells. (B) MTT assay. Cells were incubated in 24 well dishes
(1 × 104 cells/well). At 0, 2, 4, and 6 days, MTT assays were performed. (C) Soft agar colony formation assay. The plates were incubated at 37°C in
a humidified incubator for 21 days. Colonies larger than 1 mm in diameter were counted. (D) Sphere formation assay. Cells (5,000) were mixed
with Matrigel (1:1 ratio, total 200 μl) and placed in rim of well of 24well culture plates. After solidified, 1 ml of medium was added and grown for
21 days. Pictures were taken under microscope. (E) Migration assay. The migrative potential of different cells was assessed using the 8 μm pore
Transwell system. Cells (1 × 105) were resuspended in 100 μl serum free medium and added in the upper compartment. 600 μl of 20% CS-FBS
medium was placed in the lower compartment. After 24 hours, cells that had not migrated were removed from the upper face of the membranes
with cotton swabs. The average number of cells per field of view (five random fields per membrane) was counted at × 20 magnification. All
experiments samples were plated in triplicate.
Figure 4 Activation of self-renewal/proliferation related signaling pathways in LNCaP S/P cells. (A) The probably related signaling pathways in parental,
S/P, and non S/P cells of LNCaP cell line were examined by Western blot analysis, such as AKT, Bcl-2, c-Myc, MAPK (Erk1/2) and Stat3. (B) Cells (LNCaP
S/P) were infected with lentivirus carrying V/AR and the levels of AR, p-Akt, bcl-2, and c-Myc were examined by Western blot analysis. (C) The S/P cells
of LNCaP cell line were transfected with AR, Oligo bcl-2 siRNA, or/and c-Myc siRNA plasmids indicated. At the end of 4 days of culture after transfection,
cells were used to do MTT assay.
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basal cells and intermediate cells. Some basal cells with
CSC markers may be the origin of the tumor. Recent
studies have shown that AR expression level was differ-
ent in prostate cancer cells, played a different role
[30-32]. The current research and our work showed that
AR expression was low in prostate cancer S/P cells.
Transferring ARintoS/P cells could inhibit their prolifer-
ation. AR’s roles in EMT characteristics of S/P cells and
related regulatory mechanism were not clear. In this
study we transfered AR into S/P cells with lentivirus.
Compared with that of vector S/P cells, using different
methods of immune detection, it was found that the ex-
pression of EMT markers decreased, and epithelial markers
E Cadherin expression increased. Cell proliferation, self-
renewal ability, tumorigenesis and the ability to migrate
were all restrained in AR-S/P cells. The characteristics of
EMT were restrained too. These data suggest that AR
played a dual inhibition effect on S/P cell proliferation and
EMT features.
Signaling pathways regulating prostate cancer cell
EMT included AKT, Wnt, stat3, Bcl-2, C-Myc, TGF-ß,
EGF/EGFR, Notch, MAPK and so on [33-36]. It was
shown that EMT and CSC characteristics could be regu-
lated simultaneously. Erismodegib (a Shh signaling path-
way inhibitor) could inhibit EMT and human prostate
cancer stem cell growth in NOD/SCID IL2Rγ null mice
by regulating Bmi-1 and microRNA-128[37]. In this
study we tested a large number of cell signaling
Figure 5 In vitro combinatory use of LY 294002 (inhibitor of AKT signaling molecules) with γ-TT and/or 5-AZA showed synergistic effect of killing PCa
S/P cells. (A) Soft agar colony formation assay. A cell suspension (1 × 104 cells/well) in 2 ml of 0.5% low-melting agar with RPMI 1640 was overlaid into
6well plates containing 1% agar base. The 2 ml normal medium was added on the upper cells contained agar. The plates were incubated at 37°C in a
humidified incubator for 21 days. The colonies were visualized by staining with 1% crystal violet. Colonies larger than 1 mm in diameter were counted.
(B) MTT assay. Cells were incubated in 24 well dishes (1 × 104 cells/well). At 0, 2, 4, and 6 days, MTT assays were performed.
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pathways. P-AKT, Bcl-2 and C-Myc expression were
higher in S/P cells than those in non S/P cell. When AR
was transferred into S/P cells, these three proteins ex-
pression were significantly suppressed. Then we de-
signed SiBcl-2 and Si C-Myc and they could well
restrain S/P cell proliferation. So it was suggested that
P-AKT, Bcl-2 and C-Myc were involved in this
procedure.
AR and the three signaling pathways can regulate S/P
cells proliferation. So to intervene of these pathways, LY
294002, an inhibitor of AKT signaling, γ-TT, and 5-
AZA, a de-methylating agent, were used. It was showed
that γ-TT suppressed S/P cells through the interruption
of targeting molecules including bcl-2 [38]. In addition,
γ-TT has also been reported to inhibit PI3K/Akt signal-
ing [39]. Therefore, it is possible that γ-TT might be able
to suppress S/P cells via inhibiting both PI3K/Akt signal-
ing and bcl-2 expression. The other strategy to suppress
S/P cells is to target AR directly via reversing the low ex-
pression of AR in S/P cells. It was reported that the CpG
islands in the promoter and exon 1 of AR gene in S/P
cells were highly methylated, compared to that of the
non S/P cells [40], and treatment of S/P cells with the
de-methylating agent, 5-AZA, led to significant suppres-
sion of S/P cells proliferation via inducing AR expres-
sion. Combining two or three of the reagents could
inhibit S/P cells tumorigenicity and growth efficiently.
So, it was suggested that targeting AR or related cell sig-
naling pathways could inhibit prostate cancer S/P cells
proliferation, which could be a new strategy to treat cas-
tration resistant prostate cancer (CRPC).
Conclusion
Our data showed that AR played a negative role in EMT
of PCa S/P cells, by regulating AKT cell signaling path-
way, which could be a new strategy to treat castration
resistant prostate cancer (CRPC).
Abbreviations
AR: Androgen receptor; FACS: Florescence-activated cell sorting;
CRPC: Castration resistant prostate cancer.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MZ and WL participated in the design of the study and performed the
statistical analysis. MZ, WL, ZW, HB, TR, WN, and ZS conceived of the study,
and participated in its design and coordination and helped to draft the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by Research Project Supported by Shanxi
Scholarship Council of China (2012–085), Project Supported by The Preferred
Foundation of Shanxi Study Abroad Personnel (2011[762]) Construction
Project of National Key Clinical Department of Urology (2012).
Received: 11 February 2015 Accepted: 24 April 2015
References
1. Li M, Zhang SW, Ma JH, Chen WQ, Na YQ. A comparative study on
incidence trends of prostate cancer in part of cities and counties in China.
Chin J Urol. 2009;30(6):368–70.
2. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON. Basal
epithelial stem cells are efficient targets for PCa initiation. Proc Natl Acad Sci
U S A. 2010;107(6):2610–5.
3. Mulholland DJ, Xin L, Morim A, Lawson D, Witte O, Wu H. Lin-Sca-1 + CD49f
high stem/ progenitors are tumor-initiating cells in the Pten-null prostate
cancer model. Cancer Res. 2009;69(22):8555–62.
4. Taylor RA, Toivanen R, Risbridger GP. Stem cells in prostate cancer: treating
the root of the problem. Endocr-Relat Cancer. 2010;17(4):273–85.
5. Lang SH, Frame FM, Collins AT. Prostate cancer stem cells. J Pathol.
2009;217(2):299–306.
6. Blum R, Gupta R, Burger PE, Ontiveros CS, Salm SN, Xiong X, et al. Molecular
signatures of prostate stem cells reveal novel signaling pathways and
provide insights into prostate cancer. PLoS One. 2009;4(5):e5722.
7. Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, García-Echeverría C,
et al. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of
PCa stem-like cell populations. Proc Natl Acad Sci U S A. 2009;106(1):268–73.
8. Bisson I, Prowse DM. WNT signaling regulates self-renewal and differentiation
of PCa cells with stem cell characteristics. Cell Res. 2009;19(6):683–97.
9. Gu L, Vogiatzi P, Puhr M, Dagvadorj A, Lutz J, Ryder A, et al. Stat5 promotes
metastatic behavior of human PCa cells in vitro and in vivo. Endocr-Relat
Cancer. 2010;17(2):481–93.
10. Ma ZF, Yue L, Xu ZL, Hao ZW, Wang DW. The change of the number of
stem/progenitor cells in human prostate cancer tissue after endocrine
therapy. Chin J Clinicians. 2012;6(23):47–51.
11. Lue HW, Yang X, Wang R, Qian W, Xu RZ, Lyles R, et al. LIV-1 promotes
prostate cancer epithelial-to-mesenchymal transition and metastasis
through HB-EGF shedding and EGFR-mediated ERK signaling. PLoS One.
2011;6(11):e27720.
12. Lim M, Chuong CM, Roy-Burman P. PI3K, Erk signaling in BMP7-induced
epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in
2- and 3-dimensional cultures. Horm Cancer. 2011;2(5):298–309.
13. Byles V, Zhu L, Lovaas JD, Chmilewski LK, Wang J, Faller DV, et al. SIRT1 induces
EMT by cooperating with EMT transcription factors and enhances prostate
cancer cell migration and metastasis. Oncogene. 2012;31(43):4619–29.
14. Sethi S, Macoska J, Chen W, Sarkar FH. Molecular signature of epithelial -
mesenchymal transition (EMT) in human prostate cancer bone metastasis.
Am J Transl Res. 2010;3(1):90–9.
15. Sun Y, Wang BE, Leong KG, Yue P, Li L, Jhunjhunwala S, et al. Androgen
deprivation causes epithelial- mesenchymal transition in the prostate:
implications for androgen-deprivation therapy. Cancer Res. 2012;72(2):527–36.
16. Ma ZF, Xu ZL, Yue L, Hao B, Tu R, Wang DW. The change of the biomarkers
of epithelial- mesenchymal transition in human prostate cancer tissue after
endocrine therapy. Chin Remedies Clin. 2014;14(7):882–4.
17. Gavert N, Ben-Ze’ev A. Coordinating changes in cell adhesion and
phenotype during EMT-like processes in cancer. Biol Rep. 2010;2:86.
18. Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S, et al. Targeting miRNAs
involved in cancer stem cell and EMT regulation: An emerging concept in
overcoming drug resistance. Drug Resist Updat. 2010;13(4):109–18.
19. Li J, Zhou BP. Activation of β-catenin and Akt pathways by Twist are critical
for the maintenance of EMT associated cancer stem cell-like characters.
BMC Cancer. 2011;11:49.
20. Wen S, Niu Y, Lee SO, Chang C. Androgen receptor (AR) positive vs
negative roles in prostate cancer cell deaths including apoptosis, anoikis,
entosis, necrosis and autophagic cell death. Cancer Treat Rev.
2014;40(1):31–40.
21. Ma ZF, Xu ZL, Yue L, Hao ZW, Wang DW. Isolation and identification of
stem/progenitor cells from human prostate cancer cell line. Chin J Cell
Stem Cell. 2012;2(4):254–60.
22. Lee SO, Ma Z, Yeh CR, Luo J, Lin TH, Lai KP, et al. New therapy targeting
differential androgen receptor signaling in prostate cancer stem/progenitor
vs non-stem/progenitor cells. J Mol Cell Biol. 2013;5(1):14–26.
23. Soo Ok L, Jing T, Chiung-Kuei H, Ma ZF, Lai KP, HsiMin H, et al. Suppressor
role of androgen receptor in proliferation of prostate basal epithelial and
progenitor cells. J Endocrinol. 2012;213(2):173–82.
24. Li P, Yang R, Gao WQ. Contributions of epithelial-mesenchymal transition
and cancer stem cells to the development of castration resistance of
prostate cancer. Mol Cancer. 2014;13:55.
Zhifang et al. BMC Biochemistry  (2015) 16:13 Page 10 of 11
25. Marín-Aguilera M, Codony-Servat J, Reig Ò, Lozano JJ, Fernández PL, Pereira
MV, et al. Epithelial-to-mesenchymal transition mediates docetaxel
resistance and high risk of relapse in prostate cancer. Mol Cancer Ther.
2014;13(5):1270–84.
26. Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, et al. Acquisition of
epithelial-mesenchymal transition and cancer stem cell phenotypes is
associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer
radioresistance. Cell Death Dis. 2013;4:e875.
27. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, et al. Epithelial to
mesenchymal transition is mechanistically linked with stem cell signatures
in prostate cancer cells. PLoS One. 2010;5(8):e12445.
28. Luo Y, Cui X, Zhao J, Han Y, Li M, Lin Y, et al. Cells susceptible to epithelial-
mesenchymal transition are enriched in stem-like side population cells from
prostate cancer. Oncol Rep. 2014;31(2):874–84.
29. Kahn B, Collazo J, Kyprianou N. Androgen receptor as a driver of therapeutic
resistance in advanced prostate cancer. Int J Biol Sci. 2014;10(6):588–95.
30. Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, et al. Androgen
receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl
Acad Sci U S A. 2008;105(34):12182–7.
31. Niu Y, Chang TM, Yeh S, Ma WL, Wang YZ, Chang C. Differential androgen
receptor signals in different cells explain why androgen-deprivation therapy
of prostate cancer fails. Oncogene. 2010;29(25):3593–604.
32. Jacob S, Nayak S, Fernandes G, Barai RS, Menon S, Chaudhari UK, et al.
Androgen receptor as a regulator of ZEB2 expression and its implications in
epithelial -to-mesenchymal transition in prostate cancer. Endocr-Relat
Cancer. 2014;21(3):473–86.
33. Thakur N, Gudey SK, Marcusson A, Fu JY, Bergh A, Heldin CH, Landström M.
TGFβ-induced invasion of prostate cancer cells is promoted by c-Jun-
dependent transcriptional activation of Snail1. Cell Cycle 2014. [Epub ahead
of print].
34. Morimoto K, Tanaka T, Nitta Y, Ohnishi K, Kawashima H, Nakatani T. NEDD9
crucially regulates TGF-β-triggered epithelial-mesenchymal transition and
cell invasion in prostate cancer cells: involvement in cancer progressiveness.
Prostate. 2014;74(8):901–10.
35. Liu K, Park C, Chen H, Hwang J, Thimmegowda NR, Bae EY, et al. Eupafolin
suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-
mediated Akt signaling. Mol Carcinog. 2014. [Epub ahead of print].
36. Li X, Xu Y, Chen Y, Chen S, Jia X, Sun T, et al. SOX2 promotes tumor
metastasis by stimulating epithelial-to-mesenchymal transition via regulation
of WNT/β-catenin signal network. Cancer Lett. 2013;336(2):379–89.
37. Nanta R, Kumar D, Meeker D, Rodova M, Van Veldhuizen PJ, Shankar S, et al.
NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and
human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by
regulating Bmi-1 and microRNA-128. Oncogenesis. 2013;2:e42.
38. Luk SU, Yap WN, Chiu YT, Lee DT, Ma S, Lee TK, et al. Gamma-tocotrienol as
an effective agent in targeting prostate cancer stem cell-like population. Int
J Cancer. 2011;128(9):2182–91.
39. Samant GV, Sylvester PW. Gamma-tocotrienol inhibits ErbB3-dependent
PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells. Cell
Proli. 2006;39(6):563–74.
40. Tian J, Lee SO, Liang L, Luo J, Huang CK, Li L, et al. Targeting the unique
methylation pattern of androgen receptor (AR) promoter in prostate stem/
progenitor cells with 5-aza-2-deoxycytidine (5-AZA) leads to suppressed
prostate tumorigenesis. J Biol Chem. 2012;287(47):39954–66.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Zhifang et al. BMC Biochemistry  (2015) 16:13 Page 11 of 11
